The objective of this study was to determine the therapeutic and residual efficacy of a topically applied combination of cyphenothrin (40 %) and pyriproxyfen (2 %) against the tick Haemaphysalis elliptica and the flea Ctenocephalides felis on dogs. Twelve dogs were infested with 50 ticks 2 days before they were treated and with approximately 100 fleas 6 days before treatment and again 2 days before treatment and with 50 ticks and approximately 100 fleas at weekly intervals thereafter. They were ranked according to their flea counts and sex 5 days before treatment and randomly allocated to an untreated control group of 6 dogs and a treated group of 6 dogs. Ticks and fleas were collected from the dogs 48 h after treatment and 48 h after each infestation and live and dead ticks and live fleas were counted. The counts of ticks and fleas were transformed to geometric means, and efficacy was calculated by comparing these means. The product had a therapeutic efficacy of 83.1 % against H. elliptica and 97.5 % against C. felis 2 days after treatment. The residual period of protection during which efficacy was > 90% was 5 weeks for both H. elliptica and C. felis.

The objective of this study was to determine the species composition of ixodid ticks infesting domestic dogs in the northwestern region of the Northern Cape Province of South Africa and in Namibia. Ticks were collected from February 2008 to January 2009 from dogs presented for a variety of reasons at a veterinary clinic in the Northern Cape Province and at 3 clinics in Namibia. The ticks collected at each place were pooled separately for each month at each locality. Eleven ixodid tick species were collected from dogs in the Northern Cape Province and new locality records for Haemaphysalis colesbergensis and Ixodes rubicundus, new locality and host records for Hyalomma glabrum, and a new host record for Rhipicephalus neumanni are reported. Six tick species were collected from dogs at the 3 clinics in Namibia. The most numerous species on dogs in both countries was R. sanguineus. The present results increase the total number of ixodid tick species collected from dogs in South Africa from 25 to 28.

In order to determine the extent of acaricide resistance in the eastern region of the Eastern Cape Province 1-, 2- and 3-host ticks were collected from cattle at 59 dip-tanks over a period of 2 years. These ticks were tested for resistance against 3 compounds, namely amitraz, cypermethrin and chlorfenvinphos. The Shaw Larval Immersion Test detected emerging resistance to amitraz in Rhipicephalus (Boophilus) microplus at 2 dip-tanks and resistance at a 3rd. It also revealed resistance in this tick to cypermethrin at 1 dip-tank and emerging resistance to chlorfen vinphos at 8 dip-tanks and resistance at 2. Rhipicephalus evertsi evertsi was susceptible to amitraz and cypermethrin at all dip-tanks, but showed emerging resistance to chlorfenvinphos at 7 dip-tanks and resistance at 4. Rhipicephalus appendiculatus was susceptible to amitraz and chlorfenvinphos at all dip-tanks and demonstrated emerging resistance to cypermethrin at 1. With the exception of R. (B.) microplus, in which emerging resistance to amitraz was detected at 1 dip-tank by the Reproductive Estimate Test, all 3 tick species at all dip-tanks at which sufficient numbers of ticks had been collected were susceptible to the 3 acaracides in both the Egg Laying Test and the Reproductive Estimate Test. The localities at which acaricide resistance was recorded were mapped.

The purpose of this study was to determine the species spectrum of ticks infesting goats owned by resource-limited farmers in the state-owned communal land areas of Zimbabwe. Ticks were collected from goats at a single locality within each of 5 communal land areas, and a total of 14 ixodid tick species was recovered. The most numerous tick was Rhipicephalus evertsi evertsi, which was present in all areas at each sampling, and a Rhipicephalus sp. (near R. punctatus), which was most abundant on goats in the central regions of Zimbabwe during the March rainy season. Amblyomma hebraeum was present on goats in all areas sampled. In the eastern central region its distribution overlapped that of Amblyomma variegatum, while in the northwest it overlapped those of both Amblyomma marmoreum and A. variegatum. Hyalomma truncatum was present at all localities, whereas only a single Hyalomma rufipes was recovered. Rhipicephalus appendiculatus was collected from goats in the moist, slightly cooler regions, while the few Rhipicephalus zambeziensis recovered were present in the hotter, drier regions. Species recorded in lower numbers were Rhipicephalus (Boophilus) decoloratus, Rhipicephalus lunulatus, Rhipicephalus simus, Rhipicephalus tricuspis and Rhipicephalus turanicus. Attachment in the inter-digital space of adult A. hebreaum and H. truncatum was sometimes associated with lameness.

The contributions of cytokines to the development and progression of disease in a mouse model of retrovirus-induced immunodeficiency (MAIDS) are controversial. Some studies have indicated an etiologic role for type 2 cytokines, while others have emphasized the importance of type 1 cytokines. We have used mice deficient in expression of IL-4, IL-10, IL-4 and IL-10, IFN-<FONT FACE="Symbol">g</font>, or ICSBP - a transcriptional protein involved in IFN signaling - to examine their contributions to this disorder. Our results demonstrate that expression of type 2 cytokines is an epiphenomenon of infection and that IFN-<FONT FACE="Symbol">g</font> is a driving force in disease progression. In addition, exogenously administered IL-12 prevents many manifestations of disease while blocking retrovirus expression. Interruption of the IFN signaling pathways in ICSBP-/- mice blocks induction of MAIDS. Predictably, ICSBP-deficient mice exhibit impaired responses to challenge with several other viruses. This immunodeficiency is associated with impaired production of IFN-<FONT FACE="Symbol">g</font> and IL-12. Unexpectedly, however, the ICSBP-/- mice also develop a syndrome with many similarities to chronic myelogenous leukemia in humans. The chronic phase of this disease is followed by a fatal blast crisis characterized by clonal expansions of undifferentiated cells. ICSBP is thus an important determinant of hematopoietic growth and differentiation as well as a prominent signaling molecule for IFNs